C4 Therapeutics
C4 Therapeutics Logo
About C4 Therapeutics
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies that degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidates include Cemsidomide, targeting multiple myeloma and non-Hodgkin lymphomas, CFT1946 for BRAF V600 mutant cancers, and CFT8919 for EGFR-mutant non-small cell lung cancer. The company collaborates with several global pharmaceutical firms and is headquartered in Watertown, Massachusetts.
Address
490 Arsenal Way, Suite120
Watertown, 02472
United States
Year founded
2015
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
